Ask AI
Bexobrutideg in RR CLL
Phase Ia/b Trial of Bexobrutideg, a BTK Degrader, in Adults With Relapsed/Refractory CLL/SLL

Released: December 19, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 19, 2025